Lee Moon Su agreed to acquire 98.039216% stake in NVC 2019 Bio Health Care Investment Association from InnoTherapy, Inc. (KOSDAQ:A246960) for approximately KRW5 billion on June 26, 2023. For the year ended December 31, 2022 Total Assets KRW6.3 billion, Net Loss KRW5 million and Total Common Equity KRW6.3 billion. The transaction is expected to close on June 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,730 KRW | +0.69% | -0.80% | -1.58% |
1st Jan change | Capi. | |
---|---|---|
-1.58% | 46.91M | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B | |
-4.33% | 8.5B |
- Stock Market
- Equities
- A246960 Stock
- News SCL Science Inc.
- Lee Moon Su agreed to acquire 98.039216% stake in NVC 2019 Bio Health Care Investment Association from InnoTherapy, Inc. for approximately KRW5 billion.